CorMedix IncNASDAQ:CRMD
- LAST PRICE5.2600
- TODAY'S CHANGE (%)0.0200 (0.3817%)
- Bid / Lots5.2000/ 14
- Ask / Lots5.3000/ 100
- Open / Previous Close5.2000 / 5.2400
- Day Range
- 52 Week Range
- Volume373,841
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 5817 | 5.2 |
| 09:36 ET | 200 | 5.2 |
| 09:38 ET | 200 | 5.22 |
| 09:41 ET | 3000 | 5.17 |
| 09:43 ET | 400 | 5.165 |
| 09:45 ET | 16457 | 5.18 |
| 09:48 ET | 1125 | 5.2172 |
| 09:50 ET | 200 | 5.21 |
| 09:52 ET | 100 | 5.22 |
| 09:54 ET | 1000 | 5.205 |
| 09:56 ET | 218 | 5.19 |
| 09:57 ET | 400 | 5.17 |
| 10:01 ET | 1336 | 5.19 |
| 10:03 ET | 1395 | 5.21 |
| 10:06 ET | 492 | 5.19 |
| 10:10 ET | 200 | 5.2 |
| 10:12 ET | 4671 | 5.205 |
| 10:14 ET | 544 | 5.2 |
| 10:15 ET | 500 | 5.22 |
| 10:17 ET | 200 | 5.235 |
| 10:19 ET | 2900 | 5.265 |
| 10:21 ET | 1173 | 5.2346 |
| 10:26 ET | 100 | 5.23 |
| 10:28 ET | 1617 | 5.23 |
| 10:30 ET | 200 | 5.23 |
| 10:32 ET | 316 | 5.22 |
| 10:33 ET | 300 | 5.22 |
| 10:35 ET | 9984 | 5.233 |
| 10:37 ET | 400 | 5.235 |
| 10:39 ET | 600 | 5.23 |
| 10:44 ET | 346 | 5.21 |
| 10:46 ET | 6942 | 5.215 |
| 10:48 ET | 1300 | 5.19 |
| 10:50 ET | 700 | 5.19 |
| 10:51 ET | 3702 | 5.2101 |
| 10:55 ET | 300 | 5.19 |
| 10:57 ET | 200 | 5.2 |
| 11:00 ET | 1100 | 5.185 |
| 11:02 ET | 921 | 5.19 |
| 11:04 ET | 104 | 5.195 |
| 11:06 ET | 3542 | 5.2 |
| 11:08 ET | 5777 | 5.225 |
| 11:09 ET | 3800 | 5.22 |
| 11:20 ET | 969 | 5.225 |
| 11:22 ET | 2100 | 5.2203 |
| 11:31 ET | 846 | 5.19 |
| 11:33 ET | 200 | 5.19 |
| 11:36 ET | 2682 | 5.18 |
| 11:38 ET | 100 | 5.17 |
| 11:40 ET | 1200 | 5.19 |
| 11:44 ET | 500 | 5.185 |
| 11:49 ET | 600 | 5.195 |
| 11:54 ET | 100 | 5.19 |
| 12:00 ET | 200 | 5.18 |
| 12:03 ET | 535 | 5.19 |
| 12:05 ET | 100 | 5.18 |
| 12:09 ET | 100 | 5.19 |
| 12:12 ET | 492 | 5.1899 |
| 12:18 ET | 100 | 5.18 |
| 12:20 ET | 451 | 5.18 |
| 12:21 ET | 200 | 5.18 |
| 12:23 ET | 200 | 5.18 |
| 12:27 ET | 200 | 5.19 |
| 12:32 ET | 500 | 5.2 |
| 12:41 ET | 1579 | 5.205 |
| 12:45 ET | 254 | 5.21 |
| 12:48 ET | 113 | 5.205 |
| 12:52 ET | 200 | 5.195 |
| 12:54 ET | 402 | 5.19 |
| 12:56 ET | 100 | 5.19 |
| 12:57 ET | 100 | 5.19 |
| 12:59 ET | 4061 | 5.2 |
| 01:01 ET | 254 | 5.214 |
| 01:03 ET | 200 | 5.21 |
| 01:06 ET | 100 | 5.215 |
| 01:08 ET | 200 | 5.21 |
| 01:10 ET | 200 | 5.205 |
| 01:12 ET | 2273 | 5.23 |
| 01:14 ET | 100 | 5.235 |
| 01:15 ET | 5859 | 5.24 |
| 01:17 ET | 12357 | 5.25 |
| 01:19 ET | 400 | 5.245 |
| 01:24 ET | 10606 | 5.215 |
| 01:26 ET | 15348 | 5.25 |
| 01:28 ET | 247 | 5.255 |
| 01:30 ET | 500 | 5.255 |
| 01:32 ET | 291 | 5.255 |
| 01:35 ET | 8344 | 5.275 |
| 01:37 ET | 2300 | 5.27 |
| 01:39 ET | 400 | 5.275 |
| 01:42 ET | 7193 | 5.275 |
| 01:48 ET | 3315 | 5.2841 |
| 01:50 ET | 1712 | 5.285 |
| 01:51 ET | 261 | 5.285 |
| 01:53 ET | 1453 | 5.2901 |
| 01:55 ET | 100 | 5.295 |
| 01:57 ET | 100 | 5.295 |
| 02:00 ET | 100 | 5.2928 |
| 02:02 ET | 2560 | 5.285 |
| 02:04 ET | 2584 | 5.285 |
| 02:06 ET | 2000 | 5.285 |
| 02:08 ET | 100 | 5.285 |
| 02:11 ET | 100 | 5.285 |
| 02:13 ET | 1058 | 5.285 |
| 02:15 ET | 1200 | 5.29 |
| 02:22 ET | 1000 | 5.298 |
| 02:24 ET | 3000 | 5.3014 |
| 02:26 ET | 100 | 5.305 |
| 02:27 ET | 652 | 5.305 |
| 02:29 ET | 3378 | 5.325 |
| 02:31 ET | 1019 | 5.32 |
| 02:33 ET | 205 | 5.315 |
| 02:42 ET | 100 | 5.31 |
| 02:44 ET | 521 | 5.31 |
| 02:51 ET | 100 | 5.31 |
| 02:54 ET | 5907 | 5.3 |
| 02:56 ET | 300 | 5.3031 |
| 02:58 ET | 3300 | 5.295 |
| 03:00 ET | 1750 | 5.295 |
| 03:02 ET | 1300 | 5.3 |
| 03:03 ET | 400 | 5.285 |
| 03:05 ET | 2100 | 5.2801 |
| 03:07 ET | 2800 | 5.28 |
| 03:09 ET | 574 | 5.275 |
| 03:12 ET | 1630 | 5.28 |
| 03:14 ET | 100 | 5.27 |
| 03:18 ET | 553 | 5.2718 |
| 03:20 ET | 200 | 5.275 |
| 03:21 ET | 200 | 5.275 |
| 03:23 ET | 6404 | 5.275 |
| 03:25 ET | 400 | 5.275 |
| 03:27 ET | 200 | 5.275 |
| 03:30 ET | 300 | 5.275 |
| 03:32 ET | 1050 | 5.275 |
| 03:34 ET | 2657 | 5.265 |
| 03:36 ET | 400 | 5.2675 |
| 03:38 ET | 694 | 5.265 |
| 03:39 ET | 4600 | 5.265 |
| 03:41 ET | 1329 | 5.28 |
| 03:43 ET | 1238 | 5.285 |
| 03:45 ET | 100 | 5.285 |
| 03:48 ET | 3633 | 5.305 |
| 03:52 ET | 1810 | 5.3 |
| 03:54 ET | 1200 | 5.3 |
| 03:56 ET | 7620 | 5.29 |
| 03:57 ET | 16521 | 5.26 |
| 03:59 ET | 13796 | 5.26 |
May 28, 2024
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider, from 8:30AM ET on Tuesday May 28, 2024 by Dow Jones
8:30AM ET on Tuesday May 28, 2024 by Dow Jones
May 13, 2024
DJ CorMedix Price Target Maintained With a $10.00/Share by Needham, from 5:42AM ET on Monday May 13, 2024 by Dow Jones
5:42AM ET on Monday May 13, 2024 by Dow Jones
May 10, 2024
CorMedix Inc. to Participate in Two Upcoming Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by Dow Jones
8:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones*DJ CorMedix 1Q Loss/Shr 25c >CRMD, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 289.8M | -5.7x | --- |
Cipla Ltd | 14.0B | 0.0x | --- |
Zevra Therapeutics Inc | 194.6M | -3.5x | --- |
Calliditas Therapeutics AB | 1.2B | -21.4x | --- |
Assembly Biosciences Inc | 83.5M | -1.3x | --- |
Dbv Technologies SA | 119.3M | -0.7x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $289.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
